Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

August 01, 2007; Volume 322,Issue 2

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Building Individualized Medicine: Prevention of Adverse Reactions to Warfarin Therapy
    Evgeny Krynetskiy and Patrick McDonnell
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 427-434; DOI: https://doi.org/10.1124/jpet.106.117952

BEHAVIORAL PHARMACOLOGY

  • You have access
    Relative Abuse Liability of Indiplon and Triazolam in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects
    Lawrence P. Carter, Roland R. Griffiths, Patricia E. Suess, John H. Casada, Christopher L. Wallace and John D. Roache
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 749-759; DOI: https://doi.org/10.1124/jpet.107.119693
  • You have access
    Noradrenergic Mechanisms in Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys
    Donna M. Platt, James K. Rowlett and Roger D. Spealman
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 894-902; DOI: https://doi.org/10.1124/jpet.107.121806

CARDIOVASCULAR

  • You have access
    Human Pharmacology of Naproxen Sodium
    Marta L. Capone, Stefania Tacconelli, Maria G. Sciulli, Paola Anzellotti, Luigia Di Francesco, Gabriele Merciaro, Patrizia Di Gregorio and Paola Patrignani
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 453-460; DOI: https://doi.org/10.1124/jpet.107.122283
  • You have access
    Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats
    Stephen J. Peterson, Daniel Husney, Adam L. Kruger, Rafal Olszanecki, Francesca Ricci, Luigi F. Rodella, Alessandra Stacchiotti, Rita Rezzani, John A. McClung, Wilbert S. Aronow, Susumu Ikehara and Nader G. Abraham
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 514-520; DOI: https://doi.org/10.1124/jpet.107.119479
  • You have access
    Distinct Ca2+ Requirement for NO Production between Proteinase-Activated Receptor 1 and 4 (PAR1 and PAR4) in Vascular Endothelial Cells
    Katsuya Hirano, Namie Nomoto, Mayumi Hirano, Fumi Momota, Akiko Hanada and Hideo Kanaide
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 668-677; DOI: https://doi.org/10.1124/jpet.107.121038
  • You have access
    Determination of Adenosine Effects and Adenosine Receptors in Murine Corpus Cavernosum
    Rita C. Tostes, Fernanda R. C. Giachini, Fernando S. Carneiro, Romulo Leite, Edward W. Inscho and R. Clinton Webb
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 678-685; DOI: https://doi.org/10.1124/jpet.107.122705
  • You have access
    Regulation of Protease-Activated Receptor (PAR) 1 and PAR4 Signaling in Human Platelets by Compartmentalized Cyclic Nucleotide Actions
    Matthew L. Bilodeau and Heidi E. Hamm
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 778-788; DOI: https://doi.org/10.1124/jpet.107.121830
  • You have access
    Do the Cardiovascular Effects of Angiotensin-Converting Enzyme (ACE) I Involve ACE-Independent Mechanisms? New Insights from Proline-Rich Peptides of Bothrops jararaca
    Danielle Ianzer, Robson Augusto Souza Santos, Gisele Maia Etelvino, Carlos Henrique Xavier, Jerusa de Almeida Santos, Elizabeth Pereira Mendes, Leonor Tapias Machado, Benedito Carlos Prezoto, Vincent Dive and Antônio Carlos Martins de Camargo
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 795-805; DOI: https://doi.org/10.1124/jpet.107.120873
  • You have access
    Reciprocal Regulation of Endothelial Nitric-Oxide Synthase and NADPH Oxidase by Betulinic Acid in Human Endothelial Cells
    Katja Steinkamp-Fenske, Larissa Bollinger, Hui Xu, Ying Yao, Sven Horke, Ulrich Förstermann and Huige Li
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 836-842; DOI: https://doi.org/10.1124/jpet.107.123356

CELLULAR AND MOLECULAR

  • You have access
    PDE4B5, a Novel, Super-Short, Brain-Specific cAMP Phosphodiesterase-4 Variant Whose Isoform-Specifying N-Terminal Region Is Identical to That of cAMP Phosphodiesterase-4D6 (PDE4D6)
    York-Fong Cheung, Zhengyan Kan, Philip Garrett-Engele, Irene Gall, Hannah Murdoch, George S. Baillie, Luiz Miguel Camargo, Jason M. Johnson, Miles D. Houslay and John C. Castle
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 600-609; DOI: https://doi.org/10.1124/jpet.107.122218
  • You have access
    Competitive and Cooperative Effects of Bay K8644 on the L-Type Calcium Channel Current Inhibition by Calcium Channel Antagonists
    Alexandra Zahradníková, Igor Minarovič and Ivan Zahradník
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 638-645; DOI: https://doi.org/10.1124/jpet.107.122176
  • You have access
    An Inhibitor of Casein Kinase Iϵ Induces Phase Delays in Circadian Rhythms under Free-Running and Entrained Conditions
    Lori Badura, Terri Swanson, Wendy Adamowicz, Jessica Adams, Julie Cianfrogna, Katherine Fisher, Janice Holland, Robin Kleiman, Frederick Nelson, Linda Reynolds, Kristin St. Germain, Eric Schaeffer, Barbara Tate and Jeffrey Sprouse
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 730-738; DOI: https://doi.org/10.1124/jpet.107.122846

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    A Cannabinoid Anticancer Quinone, HU-331, Is More Potent and Less Cardiotoxic Than Doxorubicin: A Comparative in Vivo Study
    Natalya M. Kogan, Michael Schlesinger, Maximilian Peters, Gergana Marincheva, Ronen Beeri and Raphael Mechoulam
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 646-653; DOI: https://doi.org/10.1124/jpet.107.120865

ENDOCRINE AND DIABETES

  • You have access
    Testing the Bipartite Model of the Sulfonylurea Receptor Binding Site: Binding of A-, B-, and A + B-Site Ligands
    Marcus Winkler, Damian Stephan, Susanne Bieger, Petra Kühner, Felix Wolff and Ulrich Quast
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 701-708; DOI: https://doi.org/10.1124/jpet.107.123224
  • You have access
    Iptakalim, a Vascular ATP-Sensitive Potassium (KATP) Channel Opener, Closes Rat Pancreatic β-Cell KATP Channels and Increases Insulin Release
    Naoko Misaki, Xia Mao, Yu-Fung Lin, Sechiko Suga, Guo-Hui Li, Qiang Liu, Yongchang Chang, Hai Wang, Makoto Wakui and Jie Wu
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 871-878; DOI: https://doi.org/10.1124/jpet.107.121129

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Inhibition of Adenosine Deaminase Attenuates Inflammation in Experimental Colitis
    Luca Antonioli, Matteo Fornai, Rocchina Colucci, Narcisa Ghisu, Federico Da Settimo, Gianfranco Natale, Olga Kastsiuchenka, Emiliano Duranti, Agostino Virdis, Cristina Vassalle, Concettina La Motta, Laura Mugnaini, Maria Cristina Breschi, Corrado Blandizzi and Mario Del Taca
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 435-442; DOI: https://doi.org/10.1124/jpet.107.122762
  • You have access
    Ciglitazone, a Peroxisome Proliferator-Activated Receptor γ Inducer, Ameliorates Renal Preglomerular Production and Activity of Angiotensin II and Thromboxane A2 in Glycerol-Induced Acute Renal Failure
    Zivar Yousefipour, Hantz Hercule, Luan Truong, Adebayo Oyekan and Mohammad Newaz
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 461-468; DOI: https://doi.org/10.1124/jpet.107.122473
  • You have access
    Functional Characterization of Human Proton-Coupled Folate Transporter/Heme Carrier Protein 1 Heterologously Expressed in Mammalian Cells as a Folate Transporter
    Yasuhiro Nakai, Katsuhisa Inoue, Naoki Abe, Mai Hatakeyama, Kin-ya Ohta, Masaki Otagiri, Yayoi Hayashi and Hiroaki Yuasa
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 469-476; DOI: https://doi.org/10.1124/jpet.107.122606
  • You have access
    Prostaglandin E2 Enhances Acetylcholine-Induced, Ca2+-Dependent Ionic Currents in Swine Tracheal Mucous Gland Cells
    Huiling Liu and Jerry M. Farley
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 501-513; DOI: https://doi.org/10.1124/jpet.107.120154
  • You have access
    Cyclic Arg-Gly-Asp Peptide-Labeled Liposomes for Targeting Drug Therapy of Hepatic Fibrosis in Rats
    Shi-Lin Du, Hong Pan, Wei-Yue Lu, Jian Wang, Jian Wu and Ji-Yao Wang
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 560-568; DOI: https://doi.org/10.1124/jpet.107.122481
  • You have access
    Glucuronidation Converting Methyl 1-(3,4-Dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a Potent Apical Sodium-Dependent Bile Acid Transporter Inhibitor, Resulting in a Hypocholesterolemic Action
    Shingo Sakamoto, Hiroyuki Kusuhara, Kenji Miyata, Hiroyuki Shimaoka, Takushi Kanazu, Yumiko Matsuo, Kohji Nomura, Noboru Okamura, Seijiro Hara, Kazutoshi Horie, Takahiko Baba and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 610-618; DOI: https://doi.org/10.1124/jpet.106.116426
  • You have access
    Neuronally Released Acetylcholine Acts on the M2 Muscarinic Receptor to Oppose the Relaxant Effect of Isoproterenol on Cholinergic Contractions in Mouse Urinary Bladder
    Frederick J. Ehlert, Simon Ahn, Kirk J. Pak, Grace J. Park, Marline S. Sangnil, John A. Tran and Minoru Matsui
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 631-637; DOI: https://doi.org/10.1124/jpet.107.121756

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

  • You have access
    Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist
    Waldemar Gonsiorek, Xuedong Fan, David Hesk, James Fossetta, Hongchen Qiu, James Jakway, Motasim Billah, Michael Dwyer, Jianhua Chao, Gregory Deno, Art Taveras, Daniel J. Lundell and R. William Hipkin
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 477-485; DOI: https://doi.org/10.1124/jpet.106.118927
  • You have access
    A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation
    Richard W. Chapman, Michael Minnicozzi, Chander S. Celly, Jonathan E. Phillips, Ted T. Kung, R. William Hipkin, Xuedong Fan, Diane Rindgen, Gregory Deno, Richard Bond, Waldemar Gonsiorek, Motasim M. Billah, Jay S. Fine and John A. Hey
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 486-493; DOI: https://doi.org/10.1124/jpet.106.119040
  • You have access
    Antigen-Specific Suppression of Experimental Autoimmune Encephalomyelitis by a Novel Bifunctional Peptide Inhibitor
    Naoki Kobayashi, Hitomi Kobayashi, Leo Gu, Thomas Malefyt and Teruna J. Siahaan
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 879-886; DOI: https://doi.org/10.1124/jpet.107.123257
  • You have access
    Antiarthritic Effects of Relaxin, in Combination with Estrogen, in Rat Adjuvant-Induced Arthritis
    Karen Santora, Cordelia Rasa, Denise Visco, Bernard G. Steinetz and Carol A. Bagnell
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 887-893; DOI: https://doi.org/10.1124/jpet.107.122903

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

  • You have access
    Human Hydroxysteroid Sulfotransferase SULT2B1 Pharmacogenomics: Gene Sequence Variation and Functional Genomics
    Yuan Ji, Irene Moon, Jelena Zlatkovic, Oreste E. Salavaggione, Bianca A. Thomae, Bruce W. Eckloff, Eric D. Wieben, Daniel J. Schaid and Richard M. Weinshilboum
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 529-540; DOI: https://doi.org/10.1124/jpet.107.122895
  • You have access
    Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Family
    Ying Chen, Shuzhong Zhang, Marco Sorani and Kathleen M. Giacomini
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 695-700; DOI: https://doi.org/10.1124/jpet.107.123554
  • You have access
    Flavonoid Glycosides Are Not Transported by the Human Na+/Glucose Transporter When Expressed in Xenopus laevis Oocytes, but Effectively Inhibit Electrogenic Glucose Uptake
    Gabor Kottra and Hannelore Daniel
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 829-835; DOI: https://doi.org/10.1124/jpet.107.124040
  • You have access
    Dehydrogenation of Indoline by Cytochrome P450 Enzymes: A Novel “Aromatase” Process
    Hao Sun, William J. Ehlhardt, Palaniappan Kulanthaivel, Diane L. Lanza, Christopher A. Reilly and Garold S. Yost
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 843-851; DOI: https://doi.org/10.1124/jpet.107.121723

NEUROPHARMACOLOGY

  • You have access
    Activation of a Novel Injury-Induced Calcium-Permeable Channel That Plays a Key Role in Causing Extended Neuronal Depolarization and Initiating Neuronal Death in Excitotoxic Neuronal Injury
    Laxmikant S. Deshpande, David D. Limbrick, Sompong Sombati and Robert J. DeLorenzo
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 443-452; DOI: https://doi.org/10.1124/jpet.107.123182
  • You have access
    Effects of Lamotrigine Alone and in Combination with MK-801, Phenobarbital, or Phenytoin on Cell Death in the Neonatal Rat Brain
    Irina Katz, Jinsook Kim, Karen Gale and Alexei Kondratyev
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 494-500; DOI: https://doi.org/10.1124/jpet.107.123133
  • You have access
    The Effect of Recombinant Human Erythropoietin on Neurovasculature Repair after Focal Ischemic Stroke in Neonatal Rats
    Christine L. Keogh, Shan Ping Yu and Ling Wei
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 521-528; DOI: https://doi.org/10.1124/jpet.107.121392
  • You have access
    Pharmacokinetics and Amyloid Plaque Targeting Ability of a Novel Peptide-Based Magnetic Resonance Contrast Agent in Wild-Type and Alzheimer's Disease Transgenic Mice
    Karunya K. Kandimalla, Thomas M. Wengenack, Geoffry L. Curran, Emily J. Gilles and Joseph F. Poduslo
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 541-549; DOI: https://doi.org/10.1124/jpet.107.119883
  • You have access
    Antiepileptic Drugs Affect Neuronal Androgen Signaling via a Cytochrome P450-Dependent Pathway
    Marcel Gehlhaus, Nina Schmitt, Benedikt Volk and Ralf P. Meyer
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 550-559; DOI: https://doi.org/10.1124/jpet.107.120303
  • You have access
    Benzodiazepine Withdrawal-Induced Glutamatergic Plasticity Involves Up-Regulation of GluR1-Containing α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptors in Hippocampal CA1 Neurons
    Jun Song, Guofu Shen, L. John Greenfield and Elizabeth I. Tietz
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 569-581; DOI: https://doi.org/10.1124/jpet.107.121798
  • You have access
    Atrial Natriuretic Peptide Reduces Ischemia/Reperfusion-Induced Spinal Cord Injury in Rats by Enhancing Sensory Neuron Activation
    Takuya Nakayama, Naoaki Harada, Miki Asano, Norikazu Nomura, Takayuki Saito, Akira Mishima and Kenji Okajima
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 582-590; DOI: https://doi.org/10.1124/jpet.107.120725
  • You have access
    Galantamine Postischemia Provides Neuroprotection and Memory Recovery against Transient Global Cerebral Ischemia in Gerbils
    Silvia Lorrio, Mónica Sobrado, Esperanza Arias, José M. Roda, Antonio G. García and Manuela G. López
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 591-599; DOI: https://doi.org/10.1124/jpet.107.122747
  • You have access
    Pharmacological, Pharmacokinetic, and Primate Analgesic Efficacy Profile of the Novel Bradykinin B1 Receptor Antagonist ELN441958
    Jon E. Hawkinson, Balazs G. Szoke, Albert W. Garofalo, Dennis S. Hom, Hongbing Zhang, Mark Dreyer, Juri Y. Fukuda, Linda Chen, Bhushan Samant, Stellanie Simmonds, Karla P. Zeitz, Angie Wadsworth, Anna Liao, Raymond A. Chavez, Wes Zmolek, Lany Ruslim, Michael P. Bova, Ryan Holcomb, Eduardo R. Butelman, Mei-Chuan Ko and Annika B. Malmberg
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 619-630; DOI: https://doi.org/10.1124/jpet.107.120352
  • You have access
    Sexually Dimorphic Recruitment of Spinal Opioid Analgesic Pathways by the Spinal Application of Morphine
    Nai-Jiang Liu, Hans von Gizycki and Alan R. Gintzler
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 654-660; DOI: https://doi.org/10.1124/jpet.107.123620
  • You have access
    Low Sensitivity of the Positron Emission Tomography Ligand [11C]Diprenorphine to Agonist Opiates
    Susan P. Hume, Anne R. Lingford-Hughes, Valerie Nataf, Ella Hirani, Rabia Ahmad, Andrew N. Davies and David J. Nutt
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 661-667; DOI: https://doi.org/10.1124/jpet.107.121749
  • You have access
    CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties
    Kazunari Nakao, Akio Murase, Hiroyuki Ohshiro, Takako Okumura, Kana Taniguchi, Yoko Murata, Masatoshi Masuda, Tomoki Kato, Yoshiyuki Okumura and Junji Takada
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 686-694; DOI: https://doi.org/10.1124/jpet.107.122010
  • You have access
    Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis
    Thierry Bordet, Bruno Buisson, Magali Michaud, Cyrille Drouot, Pascale Galéa, Pierre Delaage, Natalia P. Akentieva, Alex S. Evers, Douglas F. Covey, Mariano A. Ostuni, Jean-Jacques Lacapère, Charbel Massaad, Michael Schumacher, Esther-Marie Steidl, Delphine Maux, Michel Delaage, Christopher E. Henderson and Rebecca M. Pruss
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 709-720; DOI: https://doi.org/10.1124/jpet.107.123000
  • You have access
    Memantine Inhibits ATP-Dependent K+ Conductances in Dopamine Neurons of the Rat Substantia Nigra Pars Compacta
    Michela Giustizieri, Maria Letizia Cucchiaroni, Ezia Guatteo, Giorgio Bernardi, Nicola B. Mercuri and Nicola Berretta
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 721-729; DOI: https://doi.org/10.1124/jpet.107.122036
  • You have access
    Applicability of the Dopamine and Rate Hypotheses in Explaining the Differences in Behavioral Pharmacology of the Chloro-Benztropine Analogs: Studies Conducted Using Intracerebral Microdialysis and Population Pharmacodynamic Modeling
    Ahmed A. Othman, Amy Hauck Newman and Natalie D. Eddington
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 760-769; DOI: https://doi.org/10.1124/jpet.107.123315
  • You have access
    Impaired Microsomal Oxidation of the Atypical Antipsychotic Agent Clozapine in Hepatic Steatosis
    Wei V. Zhang, Iqbal Ramzan and Michael Murray
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 770-777; DOI: https://doi.org/10.1124/jpet.107.124024
  • You have access
    Tumor Necrosis Factor (TNF)-Soluble High-Affinity Receptor Complex as a TNF Antagonist
    Sean D. McKenna, Georg Feger, Christie Kelton, Meijia Yang, Vittoria Ardissone, Rocco Cirillo, Pierre-Alain Vitte, Xuliang Jiang and Robert K. Campbell
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 822-828; DOI: https://doi.org/10.1124/jpet.107.119875
  • You have access
    ACP-103, a 5-Hydroxytryptamine 2A Receptor Inverse Agonist, Improves the Antipsychotic Efficacy and Side-Effect Profile of Haloperidol and Risperidone in Experimental Models
    Luis R. Gardell, Kimberly E. Vanover, Linda Pounds, Robert W. Johnson, Richard Barido, Gary T. Anderson, Isaac Veinbergs, Agnete Dyssegaard, Per Brunmark, Ali Tabatabaei, Robert E. Davis, Mark R. Brann, Uli Hacksell and Douglas W. Bonhaus
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 862-870; DOI: https://doi.org/10.1124/jpet.107.121715

TOXICOLOGY

  • You have access
    Pharmacological Characterization of Glycine-Activated Currents in HEK 293 Cells Expressing N-Methyl-D-aspartate NR1 and NR3 Subunits
    C. Thetford Smothers and John J. Woodward
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 739-748; DOI: https://doi.org/10.1124/jpet.107.123836
  • You have access
    Neuroprotection with Erythropoietin Administration Following Controlled Cortical Impact Injury in Rats
    Leela Cherian, J. Clay Goodman and Claudia Robertson
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 789-794; DOI: https://doi.org/10.1124/jpet.107.119628
  • You have access
    Sensitization and Activation of Intracranial Meningeal Nociceptors by Mast Cell Mediators
    Xi-Chun Zhang, Andrew M. Strassman, Rami Burstein and Dan Levy
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 806-812; DOI: https://doi.org/10.1124/jpet.107.123745
  • You have access
    Mechanisms Responsible for the Enhanced Antinociceptive Effects of μ-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain
    Kenneth T. Sykes, Stephanie R. White, Robert W. Hurley, Hirokazu Mizoguchi, Leon F. Tseng and Donna L. Hammond
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 813-821; DOI: https://doi.org/10.1124/jpet.107.121954
  • You have access
    Neutrophil Interaction with the Hemostatic System Contributes to Liver Injury in Rats Cotreated with Lipopolysaccharide and Ranitidine
    Xiaomin Deng, James P. Luyendyk, Wei Zou, Jingtao Lu, Ernst Malle, Patricia E. Ganey and Robert A. Roth
    Journal of Pharmacology and Experimental Therapeutics August 2007, 322 (2) 852-861; DOI: https://doi.org/10.1124/jpet.107.122069
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 322 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 322, Issue 2
1 Aug 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • PERSPECTIVES IN PHARMACOLOGY
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • ENDOCRINE AND DIABETES
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
  • METABOLISM, TRANSPORT, AND PHARMACOGENOMICS
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics